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Recent advances in genotyping technologymake it possible to utilize large-scale association analysis for disease-gene mapping. Powerful
and robust family-based association methods are crucial for successful gene mapping. We propose a family-based association method,
the generalized disequilibrium test (GDT), in which the genotype differences of all discordant relative pairs are utilized in assessing
association within a family. The improvement of the GDT over existing methods is threefold: (1) information beyond ﬁrst-degree
relatives is incorporated efﬁciently, yielding substantial gains in power in comparison to existing tests; (2) the GDT statistic is imple-
mented via a robust technique that does not rely on large sample theory, resulting in further power gains, especially at high levels of
signiﬁcance; and (3) covariates and weights based on family size are incorporated. Advantages of the GDT over existing methods are
demonstrated by extensive computer simulations and by application to recently published large-scale genome-wide linkage data
from the Type 1DiabetesGenetics Consortium (T1DGC). In our simulations, theGDTconsistently outperforms other tests for a common
disease and frequently outperforms other tests for a rare disease; the power improvement is > 13% in 6 out of 8 extended pedigree
scenarios. All of the six strongest associations identiﬁed by the GDT have been reported by other studies, whereas only three or four
of these associations can be identiﬁed by existing methods. For the T1D association at gene UBASH3A, the GDT resulted in a
genome-wide signiﬁcance (p ¼ 4.3 3 106), much stronger than the published signiﬁcance (p ¼ 104).Introduction
Recent advances in genotyping technology make it
possible to utilize large-scale association analysis for
disease-gene mapping. In comparison to commonly used
case-control genome-wide association (GWA) studies, the
genome-wide family-based design is also attractive for its
convenience in making use of existing family-based
phenotype data that were previously collected for linkage
scans or other purposes. When family information is prop-
erly incorporated in analysis of family-based association
data, the resulting inference is robust to population strati-
ﬁcation.1,2
Powerful and robust family-based association methods
are crucial for successful genemapping. One of the inﬂuen-
tial associationmethods is the transmission/disequilibrium
test (TDT).3 This method examines the allele transmission
disparity from heterozygote parents to their affected
offspring. Excess transmission of an allele suggests associa-
tion between that allele and the disease. The TDT was
originally proposed as a test of linkage in the presence of
association. It was later viewed as the standard of associa-
tion tests4 in which the null hypothesis is ‘‘no linkage and
no association.’’ Properties of the TDT and its extensions
have been studied previously.2,5,6
The TDT has been extended to accommodate various
family-ascertainment schemes in nuclear families. One
extension is the inclusion of missing parental data.
Because the TDTcan suffer from inﬂated type I errors under
direct use of one-parent family data7 or a naive imputation
of missing parental data,8 only families with complete364 The American Journal of Human Genetics 85, 364–376, Septemparental data can be included in the TDT analysis. The
1-TDT9 was proposed to address one-parent family data.
The S-TDT10 and equivalent tests11,12 were developed for
no-parent sibship data, and the power in this scenario
can be further improved by imputing missing parental
data.13,14 Another extension to the TDT is the incorpora-
tion of general nuclear family data, for which there are
two widely used methods: the pedigree disequilibrium
test (PDT)15,16 and the family-based association test
(FBAT).14,17–19 The PDT combines parent-child transmis-
sion-disequilibrium information with discordant sibling
pair association information, whereas the FBAT presents
a general class of family-based association tests. Special
features such as haplotype analysis20 have also been devel-
oped in the context of the TDT. Simulation studies were
performed for comparing the performance of various
family-based association tests in nuclear families, and
none of the methods was found to be uniformly the
most powerful.2
In contrast to TDT extensions that test association
within a family, some recent method developments
involve examining both within- and between-family asso-
ciations. The MQLS (‘‘more-powerful’’ or ‘‘modiﬁed’’ quasi-
likelihood score) method21 considers linear regression of
genotypes on affection status while taking into account
genotype correlations among family members through
kinship coefﬁcients. This method outperforms the stan-
dard generalized estimating equations (GEE) model22
with an independent working covariance matrix when
the population prevalence of a disease is used in the
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family-based association tests that examine within-family
association.
Although many association methods for dichotomous
traits have been applied to large, well-powered, family-
based studies, none of the existing methods has taken
advantage of pedigree structural information, as with
quantitative trait association methods.23 Extended pedi-
grees are typically treated as multiple nuclear families
and, consequently, information is not utilized fully.
Another weakness of some previously proposed test statis-
tics is the dependence on large-sample approximations
due to the robust estimator built into the test statistic. In
such cases, p values can be quite unreliable if they are
much smaller than 0.05.24
In this report, we propose the generalized disequilibrium
test (GDT) for generalization of TDT-like family-based asso-
ciationmethods. This method assesses the genotype differ-
ence of all discordant relative pairs in a family and makes
use of information beyond ﬁrst-degree relative pairs. In
doing so, we extend the transmission-based TDT statistic
used for examination of parent-offspring pairs to a compar-
ison-based statistic more broadly applicable to different
types of relative pairs. Covariates and missing parental
information are incorporated. Unlike many other test
statistics that rely on large samples for their asymptotic
distributions, a robust technique involving the kinship
coefﬁcients has been implemented in the GDT, so the
test remains valid even with a relatively small number of
families of unequal size. We examine the performance of
our method by comparing it with several other association
tests through extensive computer simulations. We also
apply our method to a recently published genome-wide
linkage scan data set25 consisting of 5212 genotyped cases
with type 1 diabetes (T1D [MIM 222100]) and 4998 geno-
typed nondiabetic relatives in 2496 families.
Material and Methods
Suppose we have a set of general pedigrees. Each individual j in
family i has a binary trait, covariates in vectors Zij, and genotypes
at a series of loci. For a locus with two alleles, A and a, we deﬁne a
genotype score Xij, for the jth individual in the ith family, by the
numberofA alleles.When there aremore than twoalleles, the allele
under test is labeled as A and other alleles are labeled as a. Without
loss of generality, we assume that in the ith family with Ni geno-
typed individuals in total, the ﬁrst NAi genotyped individuals are
affected and the other NUi ¼ Ni NAi genotyped individuals are
unaffected. We consider the following score for the ith family:
SGDTi ¼
XNAi
j¼1
XNi
k¼NA
i
þ1

Xij  Xik

Cijk, (Equation 1)
in which Cijk is 1/Ni if no covariates are modeled and
Cijk ¼ 8
Ni
exp

Zij  Zik
0
a

1þ expfZij  Zik0ag3 (Equation 2)
when covariates are available. Parameters in vector a are log odds
ratios for association between the covariates and the trait, andThe Americanthey can be estimated from a standard logistic regression model
with only phenotypes and covariates. The speciﬁc form (Equation
2) for covariatemodeling is derived from the quasi-likelihood22 for
a conditional logistic regression model.26 Appendix A shows that,
without covariates, the score (Equation 1) can be derived from a
conditional logistic regression model.
The test statistic of GDT has the following form:
ZGDT ¼
P
i
SGDTiﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Var
P
i
SGDTi
s : (Equation 3)
The statistic (Equation 3) follows a standard normal distribution
approximately under the null hypothesis of no association.
The score (Equation 1) is essentially a summation of genotype
differences between all phenotypically discordant relative pairs.
Under the null hypothesis of no association between allele A
and the trait, the affected and unaffected individuals should
have the same genotype score expectations; i.e., E[Xij-Xik] ¼ 0 in
Equation 1. If no covariates aremodeled, or covariates aremodeled
independent of the genetic effect, the score (Equation 1) is
expected to be zero under the null hypothesis.
The GDT can be viewed as a generalization of the TDT, 1-TDT,
and PDT. We can see this relationship by comparing their scores
(i.e., numerator of the test statistic), because all four tests are
score tests. The score of the TDT,27 or the difference of the total
number of alleles transmitted versus not transmitted from
heterozygote parents to affected offspring, can be rewritten asP
i
P
j
P2
k¼1ðXOij XPikÞ, in which XOij and XPik are the genotype
scores for the jth affected offspring and the kth parent, respec-
tively, in the ith family. This TDTscore is a summation of genotype
differences between all discordant relative pairs in nuclear families
in which both parents are unaffected and all offspring are affected,
which is exactly the deﬁnition of the GDT score in the absence of
a covariate term (Equation 2). The 1-TDT examines all heterozy-
gote parent-homozygote offspring pairs and homozygote parent-
heterozygote offspring pairs, the same as that which the GDT
does in nuclear families in which available parents are unaffected
and all offspring are affected. The PDT combines the TDT score
with the discordant sibling pair score, which is essentially exam-
ining all discordant relative pairs in nuclear families in which
parents are unaffected.
One standard way to estimate the variance of the score is to use
an empirical moment estimator:
Var
 X
i
SGDTi
!
¼
X
i

SGDTi
2
: (Equation 4)
This variance estimator is a consistent estimator under the null
hypothesis of no association, and has been used in a number of
association tests.9,15,16 Although straightforward, the accuracy of
the estimator depends on a large number of families of comparable
sizes and similarly distributed affection status.
Here, we present a more precise way to estimate the score vari-
ance without relying on the use of large-sample theory. Under
the null hypothesis of no association, each genotype score in
a family has the same mean and variance, regardless of the affec-
tion status. Suppose mi is the mean of genotype scores in the ith
family and s2i is the variance of Xij - mi, or the within-family vari-
ance. Let p
ðiÞ
jk denote the proportion of alleles shared identically
by descent (IBD) and f
ðiÞ
jk the kinship coefﬁcient between the jth
and kth individual of the ith family. The p values can usually beJournal of Human Genetics 85, 364–376, September 11, 2009 365
estimated from a multipoint IBD computation28 in genome scans
with a dense SNP panel. In Appendix B, we show the within-
family genotype covariance CovðXij  mi,Xik  miÞ is equal to
p
ðiÞ
jk s
2
i or 2f
ðiÞ
jk s
2
i , depending on whether the IBD information is
known. This leads to VarðXij  miÞ ¼ 2fðiÞjj s2i and to
E

Xij Xik
2
¼ VarXij  miþ VarðXik  miÞ  2CovXij  mi,Xik  mi:
¼
2
	
f
ðiÞ
jj þ fðiÞkk  pðiÞjk


s2i when IBD is known
2
	
f
ðiÞ
jj þ fðiÞkk  2fðiÞjk


s2i when IBD is unknown
8<:
This suggests that within-family variance s2i can be estimated by
a moment estimator,
bs2i ¼
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, ðEquation 5Þ
and that the variance of the score (Equation 1) is
Because in many cases it is not trivial to compute the IBD
sharing because of the large number of markers and/or the large
size of pedigrees, such as in a GWA scan, we consider the use of
the kinship coefﬁcients as the default option in the GDT method.
The GDT statistic can be written as
ZGDT¼
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The GDT statistic (Equation 7) applies to both noninbred and
inbred families and to both autosomal and X-linked genes (with
the use of X chromosome-speciﬁc kinship coefﬁcients29,30).
In the presence of strong linkage, the IBD sharing is expected to
be larger than twice the kinship coefﬁcient among affected relative
pairs and unaffected relative pairs, and smaller among discordant
relative pairs. Therefore, the variance (Equation 6) with the
kinship coefﬁcients used as a default is expected to be smaller
than the variance with IBD estimates modeled, and thus linkage
contributes to the inﬂation of the test statistic. For a GWA scan,
this potential inﬂation due to strong linkage is beneﬁcial for
gene mapping. For candidate gene or ﬁne mapping studies in
which strong linkage exists and estimating IBD is more feasible,
the GDT with IBD estimates modeled should be used.
The GDT test statistic is robust in the sense that its statistical
distribution under the null hypothesis does not depend on the
genetic model of the disease. In a conditional logistic regression
model fromwhich the GDT statistic is derived, no polygenic effect
is assumed. The GDT method remains valid in the presence of
polygenes because the variance of the score in Equation 3 under
the null hypothesis involves only genotype data at a single locus.
Because the variance of the score is computed within families, the
GDT method is also robust to confounding factors that exist
between families, such as population stratiﬁcation.
Simulation
We evaluate the performance of our method in a variety of simu-
lated scenarios. We consider two types of pedigrees: nuclear fami-
lies and cousin families. Each nuclear family consists of four
siblings and one or two parents. Each cousin family has three
generations, with two children in each of the three nuclear fami-
lies. In total, we consider 12 scenarios with different combinations
of affection status, missing data pattern, and pedigree types, as
shown in Figure 1. We consider a common disease with a preva-
lence of 0.3 and a rare disease with a prevalence of 0.01. The
disease allele frequency is set at 0.3. Amultiplicative geneticmodel
with genotypic relative risk of 1.5 is assumed, which corresponds
to penetrances 0.51, 0.34, and 0.227 for the common disease and
penetrances 0.017, 0.0113, and 0.0076 for the rare disease.
We investigate six family-based association methods: the GDT,
FBAT (using the default setting14,17), PDT, GDT-PO (a variation
of GDT that considers only discordant parent-offspring pairs),
1-TDT, and TDT. We investigate performance of the FBAT with
the offset18 and empirical variance options19 in analysis of the
T1DGC data. (We considered the pedigree-based association test
(PBAT)31 method, but we do not include it in our extensive simu-
lations. Although this method was identical to the FBAT method
in nuclear families, it was consistently less powerful than the
FBAT in extended pedigrees. Comparisons of these two software
implementations are shown in Supplemental Data, available on-
line.) All methods are applied to the same simulated data sets,
composed of either 200 nuclear families or 100 cousin pedigrees
(each simulated 10,000 times). We developed an algorithm to
simulate genotypes of ascertained pedigrees efﬁciently conditional
on a particular set of known phenotypic values, such as those
shown in Figure 1. We ﬁrst simulated all founders’ genotypes at
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the disease SNP according to conditional probabilities given all
levels of affection status. We then simulated inheritance vectors
at the disease SNP according to conditional probabilities given
all levels of affection status and founders’ genotypes. Finally, we
simulated two marker SNPs for all individuals: one SNP that was
completely linked but in linkage equilibrium to the disease and
a second SNP that was not linked. Both SNPs have an allele
frequency of 0.5. The simulation algorithm has been newly imple-
mented in our computer program, Linkage Explorer.32 More
rigorous details are shown in Appendix C.
In order to examine behaviors of GDT in the presence of popu-
lation stratiﬁcation across families or population admixture
within families, we performed 10,000 simulation replicates of
200 nuclear families with four offspring, each of which has at least
one affected offspring. We compare the validity of the GDT with
the MQLS, which was not designed to be robust to population
heterogeneity. Disease penetrances of 0.2, 0.3, and 0.45 are due
to a disease SNP that is independent of a marker SNP. To examine
the effect of population stratiﬁcation across families, we simulated
100 families with an MAF ¼ 0.1 for both disease and marker SNPs
and another 100 families with an MAF ¼ 0.5 for both SNPs. To
examine the effect of population admixture within families, for
each of the 200 simulated families, one parent has an MAF ¼ 0.1
for both SNPs and the other parent has an MAF ¼ 0.5 for both
SNPs. This simulation was implemented in the R package.
T1DGC Data
We applied our methods to a recently published T1D data set from
the Type 1 Diabetes Genetic Consortium (T1DGC).25 A total of
10,394 individuals from 2496 families were genotyped by the
Center for the Inheritance of Disease Research (CIDR) with their
Illumina 6K linkage panel (~6K SNPs). The affected sibling pair
(ASP) families consisted of 5212 affected and 4998 unaffected
subjects. The samples, all of European descent, were recruited
from nine geographic regions. A template informed consent was
provided for adaptation in each country. The ethics committees
of each study site approved the study protocol, and all participants
or their surrogates gave written informed consent and assent.
N1 N2 N3 N4
C1 C2 C3 C4
C5 C6 C7 C8
Figure 1. Pedigrees Used in 12 Simula-
tion Scenarios
Concannon et al.33 identiﬁed a previ-
ously unreported association with T1D in
the UBASH3A gene (MIM 605736); this
ﬁnding was replicated in two other case-
control populations. Although this study
was designed for ASP linkage analysis,
these data also provided 3737 discordant
sibling pairs, 9391 discordant parent-
offspring pairs, and hundreds of other
discordant relative pairs. Among the 2657
ASPs in total, both parents were available
for 69.6% of the ASPs, 18.9% of the ASPs
had only a single parent, and 11.6% had
neither parent available.
We applied the GDT, GDT-PO, FBAT
(two implementations: default14,17 and
with the use of an offset18), PDT (both
PDT-SUM16 and PDT-AVG15), 1-TDT,9 and
TDT to 5638 SNPs on the 22 autosomes. Although the tests PDT-
SUM and PDT-AVG are identical in our simulated data sets in
which all families are of the same structure, these two tests differ
in the T1DGC data as a result of the distinct weights assigned to
each of the families, as denoted by C in the score (Equation 1). C
is 1 in the PDT-SUM and the inverse of the total number of trios
and discordant sibling pairs in the PDT-AVG. We calculated the
estimated genomic control (GC)34 for each scan in order to assess
the inﬂation of type I errors for each of the methods.
Results
Simulation Studies
Figure 2 shows type I error rates for ﬁve association tests at
signiﬁcance levels 0.01 and 0.001, under the null hypoth-
esis of no linkage and no association. Note that the stan-
dard errors for estimates of type I error rates in 10,000
simulations are 0.001 and 0.00032, respectively. At the
0.01 signiﬁcance level in all 12 simulation scenarios, the
GDT has type I error rates % 0.011 and all other tests
have type I error rates % 0.0123. At a signiﬁcance level of
0.001, the GDT, FBAT, and PDT have type I error rates
% 0.0011, whereas the GDT-PO and 1-TDT each have
one out of 12 type I error rates larger than 0.0013 (the inﬂa-
tion is still less than two standard errors). These results
show that all tests have proper type I error rates.
Figure S1 shows that all tests also have proper type I error
rates under the null hypothesis of no association in the
presence of linkage.
Figure 3 and Figure 4 show the power comparison of ﬁve
association tests for a common disease with a prevalence of
0.3 and a rare disease with a prevalence of 0.01. In our
simulations, the power of the TDT is the same as that of
the FBAT when parents or founders are available in
scenarios N1, N2, C2, and C8 and is 0 otherwise, so the
TDT results are not included in the ﬁgure. In all simulationThe American Journal of Human Genetics 85, 364–376, September 11, 2009 367
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Figure 2. Type I Error Rates for Five Association Tests
The prevalence of the disease is set at 0.3. The SNP under test is not linked to the disease. Either 200 nuclear families or 100 cousin
families were simulated 10,000 times.scenarios, we observed the following for both a common
and a rare disease:
(1) The GDT has the highest power, except in scenarios
N1, N2, and C8 (with complete parental data), in
which either theGDTor theGDT-POhas the highest
power; the GDT is > 13% more powerful than non-
GDT methods in scenarios C2, C4, C5, C6, and C7.
(2) The GDT consistently outperforms the PDT:
although the GDT and the PDT differ only in the
variance estimator (i.e., denominator of the
statistic) in scenario N2, the GDT outperforms the
PDT by > 3.1% at a level of 0.001 and < 1.4% at
a level of 0.01.
(3) The GDT-PO is consistently as or more powerful
than the 1-TDT and TDT: although the GDT-PO
and 1-the TDT differ only in the variance estimator
in all scenarios except C4, C5, and C7, the power
improvement of the GDT-PO over the 1-TDT can
be > 5.7% at a level of 0.001 and < 4% at a level
of 0.01 in scenario C2.
(4) When both parents are available (scenarios N1, N2,
C2, and C8), the FBAT has a power very similar to368 The American Journal of Human Genetics 85, 364–376, Septemthat of the GDT-PO and the TDT; the 1-TDT is
slightly less powerful than the three other tests.
(5) The FBAT’s performance is similar to that of the PDT
for six scenarios; in all such cases, there are two
siblings per sibship with one parent missing.
(6) In contrast to the GDT, the FBAT and the PDT do
not apply to some simulation scenarios, including
C5 and C6, in which affected sibling pair families
have incomplete parental data; the GDT handles
one-parent families better than the FBAT and the
PDT.
For a common disease, the GDT performs uniformly best
among all six tests; in addition to the ﬁve scenarios in
which the GDT consistently outperforms non-GDT
methods (by > 13% in simulations), the GDT is also >
19% more powerful than non-GDT methods in scenarios
C1 and C3 and is > 45% more powerful than the FBAT
and the PDT in scenario N4. For a rare disease, the GDT still
frequently outperforms other tests, except in nuclear fami-
lies with complete parental data, in which the TDT and its
equivalent tests, such as the FBAT and the GDT-PO, are
slightly more powerful.ber 11, 2009
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Figure 3. Power to Map a Common Disease with a Prevalence of 0.3
The power of the TDT is the same as that of the FBAT under scenarios N1, N2, C2, and C8 and is 0 otherwise.Our simulations show that the GDT statistic is robust to
population stratiﬁcation across families but is somewhat
inﬂated in the presence of population admixture within
families. In the presence of population stratiﬁcation, the
type I error rates of the GDT are maintained at 5.0% and
0.9%, respectively, for signiﬁcance levels of 0.05 and
0.01, whereas the type I error rates of the MQLS method
are 18.1% and 6.6%, respectively. In the presence of popu-
lation admixture, the type I error rates of the GDTare 8.9%
and 2.1%, respectively at signiﬁcance levels of 0.05 and
0.01, which are comparable to the type I error rates of
7.2% and 1.8% for the MQLS method.
T1DGC Data
Table 1 lists all signiﬁcant associations in the T1DGC
linkage data with p % 104 with the use of seven associa-
tion tests. Although the use of the p % 104 threshold is
somewhat arbitrary, it may be sufﬁcient to permit compar-
ison of the different methods. A Bonferroni correction
based upon 5638 SNPs requires a genome-wide signiﬁ-
cance threshold of p % 8.9 3 106 and a marginal
genome-wide signiﬁcance level of p% 1.8 3 105.
The FBAT and PDT-SUM tests have a somewhat inﬂated
GC (1.053 and 1.075, respectively). Because GC inﬂationThe Americanis not adjusted in association ﬁndings in Table 1, the re-
ported association results obtained with the use of these
two methods are inﬂated. In contrast, the GDT and
GDT-PO have a much lower GC (< 1.01). Although the
FBAT, with an ‘‘optimal’’ offset used,18 has a GC similar
to the default FBAT, none of the p values obtained with
the use of this method achieved our cutoff of 104. For
this reason, we focus the remainder of our discussion on
FBAT results obtained with the use of the default setting.
The strongest SNP associated with T1D is in the Insulin
gene (INS [MIM 176730]) on chromosome 11p,35 reported
consistently across all methods, with p ¼ 1.4 3 108 to
p ¼ 1.2 3 1011. The second most signiﬁcant association
identiﬁed by the GDT, GDT-PO, and PDT methods is
with a SNP in UBASH3A on chromosome 21.33 In compar-
ison to the published p value of 104, the reanalysis of this
SNP with the use of the GDT resulted in a stronger associ-
ation result, with p ¼ 5.9 3 106, a value that reaches
genome-wide signiﬁcance. This association was not identi-
ﬁed by the FBAT, TDT, or 1-TDT. The third most associated
SNP is in SH2B3 (MIM 605093) on chromosome 12.36 This
association was identiﬁed by the GDT, GDT-PO and 1-TDT,
with signiﬁcance ranging from p ¼ 1.63 105 to p¼ 9.93
106 (all marginally signiﬁcant). Two other consistentJournal of Human Genetics 85, 364–376, September 11, 2009 369
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Figure 4. Power to Map a Rare Disease with a Prevalence of 0.01
The power of the TDT is up to 0.3% lower than that of the FBAT under scenarios N1, N2, C2, and C8 and is 0 otherwise.association results were observed at CLEC16A (KIAA0350
[MIM 611303]) on chromosome 16,35,36 with a GDT p ¼
7.9 3 105, and at SNP rs714027, with a GDT p ¼ 7.5 3
105 on chromosome 2237. The sixth most associated
SNP from the GDT analysis is at rs169679 in the HLA
(MIM 142800) region,38 with p ¼ 1.2 3 104. This associa-
tion is surprisingly weak, considering that the HLA is the
most well-known genetic factor contributing to T1D. Over-
all, all of the top six T1D-associated SNPs from the GDT
analysis (as well as from the GDT-PO analysis) have been
reported previously,37 with p < 2 3 109. However, only
3, 2, 3, 3, and 4 of these previously reported associations
were identiﬁed by the FBAT, PDT-SUM, PDT-AVG, TDT,
and 1-TDT methods, respectively. We also tested two
methods that examined the presence of population-level
association beyond within-family associations. The MQLS
method21 incorporating the population prevalence of
T1D (0.005) was able to identify INS, SH2B3, rs714027,
and HLA at p % 104, consistent with the six top SNPs
from the GDT analysis, whereas the GEE method22 identi-
ﬁed INS, UBASH3A, rs714027, and an unknown variant on
chromosome 4. We conclude that the GDT and GDT-PO
are more powerful than several other tests for the identiﬁ-
cation of variants responsible for T1D.370 The American Journal of Human Genetics 85, 364–376, SeptemChromosome 6 has a ~100 cM region in linkage with
T1D, and the HLA region has a high LOD score of 213.2
for linkage.25 This strong linkage could potentially
contribute to the inﬂation of an association test. The GC
from the analysis of chromosome 6 for the GDT, FBAT,
PDT-SUM, PDT-AVG, TDT, GDT-PO, and 1-TDT are 1.15,
1.33, 1.18, 1.05, 1.38, 1.42, and 1.11, respectively. This
indicates that the statistics of most tests are very inﬂated.
Given that linkage disequilibrium exists only throughout
the HLA complex but in only a small portion of chromo-
some 6p, inﬂation of the test statistics at a majority of
loci may be due to linkage. When IBD information is
modeled in the GDT instead of the default of kinship coef-
ﬁcients being used, the GC reduces to 1.00 from 1.15, and
the signiﬁcance of the strongest association at rs169679
with the use of the GDT is reduced from p ¼ 1.2 3 104
to p ¼ 9.1 3 104. When an empirical variance is used
for the FBAT in testing association in the presence of
linkage,19 the GC reduces from 1.33 to 1.18 and the stron-
gest association on chromosome 6 has a p> 53 104. Both
of these methods are developed for testing association in
the presence of linkage, and neither detected notable asso-
ciation on chromosome 6. The substantial inﬂation of the
GC on chromosome 6 for the FBAT method with anber 11, 2009
Table 1. Comparison of Top Association Hits in the T1DGC Data with the Use of Seven Family-Based Association Tests
Chr SNP MAF Gene
Position
(bp)
GDT:
1.008 GC
GDT-PO:
1.002 GC
FBAT:
1.053 GC
PDT-SUM:
1.075 GC
PDT-AVG:
1.025 GC
TDT:
1.030 GC
1-TDT:
1.014 GC
11 rs1004446 0.310 INS 2126719 3.6 3 1010 1.2 3 1011 1.3 3 1011 1.4 3 108 2.5 3 109 1.8 3 1011 6.0 3 1011
21 rs876498 0.453 UBASH3A 42714896 5.9 3 106 3.3 3 105 1.0 3 105 1.0 3 104
12 rs737280 0.265 SH2B3 110679359 1.6 3 105 9.9 3 106 1.1 3 105
16 rs887864 0.327 CLEC16A 11066386 7.9 3 105 2.9 3 105 4.8 3 105 7.1 3 105 1.0 3 104
22 rs714027 0.441 (multiple) 28902325 7.5 3 105 8.0 3 105 2.2 3 105
6 rs1011094 0.475 HLA 28883961 5.0 3 105 4.3 3 105 4.1 3 105 8.7 3 105
2 rs1990760 0.365 IFIH1 162949558 9.7 3 105 4.1 3 105 9.3 3 105
6 rs169679 0.453 HLA 28964551 2.4 3 105 3.7 3 105 9.1 3 105
6 rs11908 0.405 HLA 33052724 6.7 3 105 9.9 3 105
6 rs1003979 0.477 HLA 33222149 7.1 3 105
7 rs1543851 0.374 64250422 8.4 3 105
Only associations with a p value % 0.0001 are listed, and associations that have been reported by other studies are indicated in bold. Genomic control (GC)
numbers are indicated below each test, and there is no adjustment for GC inflation in the presented association results. The FBAT method is used under the default
setting.empirical variance suggests that the GDT with IBD
modeled is a more robust association test in the presence
of linkage.
Inclusion of Covariates
The ﬂexibility of modeling in the GDT for the accommoda-
tion of environmental and genetic factors is shown in
Table 2. Four models are considered: (1) no covariates,
modeled as in Table 1; (2) sex as a covariate; 3) both sex
and INS SNP rs1004446 as covariates; and (4) sex and the
INS SNP as covariates, with IBD information incorporated
as in Equation 6. With more covariates modeled, associa-
tions become stronger at known genes. Although in theoryThe Americanthe modeling of IBD leads to a more precise test statistic,
the association results do not signiﬁcantly change, par-
tially due to weak linkage in these regions. These results
demonstrate that it is sufﬁcient to use kinship coefﬁcients
to approximate IBD estimates in the GDT statistic.
One interesting observation from our sequential
modeling analysis is that signiﬁcance of the association of
CLEC16A (KIAA0350) with T1D isweakened fromp¼ 7.93
105 to p ¼ 1.13 104 when sex is included as a covariate.
However, the signiﬁcance is p ¼ 5.7 3 105 when the INS
gene is added to sex as a covariate in the model. CLEC16A
also exhibits evidence for paternal imprinting on T1D
risk. When only mother-offspring pairs are examined inTable 2. Modeling in the GDT with Environmental and Genetic Factors
Adjusted
Chr SNP MAF Position (bp) Gene Ref
None:
1.008 GC
Sex:
1.010 GC
Sex, INS:
1.002 GC
Sex, INS, IBD:
0.987 GC
11 rs1004446 0.310 2126719 INS 35 3.6 3 1010 3.1 3 1010 N/A N/A
21 rs876498 0.453 42714896 UBASH3A 33 5.9 3 106 5.3 3 106 5.2 3 106 4.3 3 106
12 rs737280 0.265 110679359 SH2B3 36 1.6 3 105 1.5 3 105 1.1 3 105 1.1 3 105
22 rs714027 0.441 28902325 (multiple) 37 7.5 3 105 7.9 3 105 7.5 3 105 7.1 3 105
16 rs887864 0.327 11066386 CLEC16A 35 7.9 3 105 1.1 3 104 5.7 3 105 5.4 3 105
6 rs169679 0.453 28964551 HLA 38 1.2 3 104 1.1 3 104
7 rs1543851 0.374 64250422 1.3 3 104 1.5 3 104 1.1 3 104 1.2 3 104
10 rs942434 0.368 7277013 1.7 3 104
6 rs11908 0.405 33052724 HLA 38 2.0 3 104
Only associations with a p value% 0.0002 are listed, and associations that have been reported by other studies are indicated in bold. Genomic control numbers are
indicated below each model. Abbreviations are as follows: Chr, chromosome; MAF, major allele frequency; Ref, reference; GC, genomic control; IBD, identity by
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the GDT-PO, p ¼ 6.9 3 105. However, when father-
offspring pairs are examined, p ¼ 0.35 and the association
isno longer signiﬁcant. Theanalysis by1-TDTshows similar
results (p ¼ 1.2 3 104 for mother only versus p ¼ 0.71 for
father only). To our knowledge, this is the ﬁrst report of
a potential paternal imprinting effect at CLEAC16A. We
also carried out an association scan for the X chromosome,
using both the GDTand GDT-POmethods, and no associa-
tion stronger than p ¼ 2 3 104 was identiﬁed.
Implementation
All methods are computationally efﬁcient for analysis of
this data set. Two software packages with implementations
of the GDT and FBAT were compared, and we found that
the GDT offered a computational advantage. It took the
FBAT 22 MB of computer memory and 11 min on our
Linux system, whereas it took the GDT 13 MB of computer
memory and 2 min to analyze the same data set on the
same system.
Discussion
We propose a general association method that makes use
of extended pedigree structure, accommodates covariates
including known associated SNPs, appropriately handles
missing parental data, and protects from population
stratiﬁcation between families. The method, GDT,
utilizes the genotype differences of all discordant relative
pairs to assess association within a family. The GDT
consistently outperforms all other association tests in
our simulations for a common disease, and it outper-
forms other association tests in many scenarios for a
rare disease. Extensive computer simulations and the
analysis of a large-scale genome scan data set demon-
strate advantages of our method over existing family-
based association methods.
The improvement of the GDT in comparison to existing
methods is threefold: (1) information beyond ﬁrst-degree
relatives is incorporated efﬁciently, yielding substantial
gains in power in comparison to existing tests; (2) the
GDTstatistic has been implementedwith theuse of a robust
technique that does not rely on large-sample theory, result-
ing in further power gains, especially at high levels of sig-
niﬁcance in data sets consisting of a modest number of
families; and (3) covariates and weights based on family
size are incorporated directly.
The GDT statistic can be presented as a robust score test
that is derived from a conditional logistic regression
model. When the assumption of no polygenic effect does
not hold, the GDT remains valid as a robust score test,
and when the model assumption holds approximately,
the GDT enjoys superior power as a maximum-likeli-
hood-based test. The conditional logistic regression model
suggests a single weight in the test statistic for each family.
Although the PDT is a special case of the GDT in certain
nuclear families, inﬂated GC numbers for the PDT-SUM372 The American Journal of Human Genetics 85, 364–376, Septemand PDT-AVG and the large differences in p values reported
by these two PDT tests in the T1DGC data analysis may
reﬂect poor assignment of weights for each family in the
PDT statistic. The PDT-SUM gives too much weight to
larger families, and the PDT-AVG gives too little weight
to larger families. The weight used by the GDT is the
inverse of the total number of informative (genotyped
and phenotyped) individuals, and its value is between
the weights used by the two PDT methods. The presented
analysis of the T1DGC data demonstrates the advantage of
this weight.
The ability of the GDT to incorporate covariates makes it
a powerful tool for the analysis of complex traits. Markers
with signiﬁcant association can be adjusted as covariates,
facilitating the search for additional variants. This feature
is particularly important for diseases, such as T1D, with
known susceptibility loci (such as HLA and INS), which
should be accounted for in all T1D GWA analyses.
Although the PDT does not take covariates in its current
form, this feature can be adapted into the PDT via the
same approach that we have used for the GDT. The FBAT
method incorporates covariates by analyzing a quantitative
trait deﬁned by residuals from a logistic regression model
ﬁt, similar to the incorporation of offsets.18 Given that
the FBAT method fails to detect any of the T1DGC associ-
ation signals with the offset option used, the FBAT covari-
ate adjustment for a similar data set may not help the
association scan.
Although in theory, a robust association method that is
based on a full likelihood model can be more powerful
than the GDT, which is based on a conditional logistic
regression model, such a uniformly powerful method has
yet to be developed. Extensive simulations and a real data
analysis demonstrate that our method has better overall
performance than several existing methods. The GDT
outperforms the PDT in all simulations and in the T1DGC
data analysis. The GDT also outperforms the FBAT in the
case of a common disease, in extended pedigrees, and in
the case of missing parental data. For mapping genetic vari-
ants associated with a rare disease, a TDT-type method that
discards unaffected sibling data remains useful. To address
this scenario, we proposed a GDT variation, GDT-PO, effec-
tively extending the TDT to handle missing parental data.
The GDT-PO outperforms the 1-TDT and TDT in all of our
simulations and in the T1DGC data analysis.
Our method, GDT, examines within-family association
and thus is robust to population stratiﬁcation across fami-
lies. Although population admixture within families may
lead to modest inﬂation of type I error rates, any inﬂation
of GDT statistics can be detected via standard techniques,
such as genomic control.34 Our simulations (unpublished
data) suggest that methods that include between-family
associations (such as the MQLS) can offer higher power
than methods that examine only within-family associa-
tions (such as the GDT). However, this power advantage
may not be substantial in data sets with identical pedigree
structures and affection status across families (as seen inber 11, 2009
the analysis of affected sibling pairs), because the small
variation of phenotypes across families contributes little
to estimation of between-family association. Furthermore,
the locus heterogeneity of polygenes that tends to occur
between families could decrease the power more substan-
tially formethods that include between-family association.
This may explain why the GDT method was able to iden-
tify more variants than both the MQLS and GEE methods
for the T1DGC data set.
We have developed a robust technique that ensures
proper type I error rates and power. This robust estimator
for the score variance involves precise calculation of the
covariance of genotype scores among family members
with the use of kinship coefﬁcients or IBD estimates. In
comparison to an asymptotic robust estimator, such as
that being implemented in the PDT and 1-TDT, our robust
estimator relies less on large numbers of families or similar
family structures. Our simulations show that a test con-
structed with the use of our precise variance estimator
consistently outperforms existing tests that use asymptotic
variance estimators, especially at a lower level of signiﬁ-
cance. A similar robust technique has been successfully
applied to robust quantitative trait linkage analysis.32,39,40
It is straightforward to extend our robust technique to
family-based quantitative trait association tests. We have
implemented such a robust test for a quantitative trait
association analysis (see details in Appendix D) that
improved a previously reported association test,30 and
preliminary simulations (unpublished data) show that
our robust test can maintain proper type I error rates and
power even when individuals do not have identical pheno-
typic distributions. We also implemented an extension of
the GDT method that allows testing association of haplo-
types, in which case a haplotype is coded in the same
way as an allele for a marker with multiple alleles.
Although our robust technique in its current form does
not apply to imputed genotypes that carry uncertainty,30
a standard robust technique that uses the asymptotic vari-
ance estimator (Equation 4) allows imputed genotypes and
may provide substantial gains in power when applied to
family-based association analysis.
The GDT and variations such as GDT-PO have been im-
plemented in a user-friendly software package called the
GDT. This software shares many nice features, as well as
Cþþ source code, with the widely used software package
Merlin.28 The GDT is similar to Merlin in many aspects,
such as the capacity to handle large and complex pedi-
grees. In addition, each allele is coded with 4 bits (i.e.,
a half byte) in the GDT package, so that thousands of indi-
viduals genotyped at hundreds of thousands of SNPs from
a GWAS can be analyzed rapidly on a standard workstation
with 2 GB of computer memory, and gene mapping that
uses genetic markers with up to 15 alleles can still be
carried out. This software package runs on multiple plat-
forms, including Linux, UNIX, and Windows operating
systems, and is freely available at the authors’ website to
facilitate its use in analysis of current and future GWAS.The AmericanAppendix A: GDT as a Robust Score Test
of a Conditional Logistic Regression Model
We show that the score (Equation 1) is the score for the
likelihood of a conditional logistic regression model under
the null hypothesis of no association.
To simplify presentation, we focus on the likelihood of a
single family without covariates. Suppose that in this
family there are N individuals in total, among which the
ﬁrstA individuals are affected and the remainingU individ-
uals are unaffected. Let Yi denote an indicator of whether
the ith individual is affected and Xi denote the count of
a certain allele at the marker under test for the ith indi-
vidual. A logistic regression model is
log
PrðYi ¼ 1Þ
1 PrðYi ¼ 1Þ ¼ mþ bXi,
in which b is the odds ratio for association between the
allele and the disease. Throughout this appendix, we
assume that disease statuses of family members are uncor-
related, conditional on genotypes at the marker being
tested; i.e., we assume no polygenic effect. The likelihood
that the ﬁrst A individuals are affected, conditional upon
the fact that there are N affected individuals in total, is
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in which elements of a set Sk index affected individuals in
the kth possible scenario that A out of N individuals are
affected. The log-likelihood is
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Under the null hypothesis of no association, the likeli-
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The summation of the above statistics over all families
yields exact expression, as in Equation 1.
Note that the validity of the score test (Equation 7)
depends only on the variance estimator of the score.
Even if the assumption of the conditional logistic regres-
sion model does not hold, our score test (Equation 7)
remains valid. When the conditional logistic regression
model holds approximately, our score test statistic (Equa-
tion 7) enjoys many ‘‘optimal’’ properties as a maximum-
likelihood-based test.
Appendix B: Within-Family Genotype Covariance
between a Pair of Relatives
The genotype score Xij is coded as the allele counts for the
jth individual in the ith family. Each Xij in the ith family
has the same mean mi, and each Xij - mi has the same vari-
ance s2i . Because the genotype score Xij can be represented
as the sum of two allelic effects, X
ð1Þ
ij and X
ð2Þ
ij , we have:P2
s¼1
Var
	
XðsÞij  mi=2


¼ VarXij  mi ¼ s2i :
Thus, the within-family covariance between genotype
scores from a pair of relatives is:
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:
When IBD information is known or can be estimated, we
have the following covariance at autosomal genes in non-
inbred families:
Cov

Xij  mi,Xik  mi
 ¼ pðiÞjk s2i :
Because the kinship coefﬁcient is the probability
that two identical alleles will be sampled from a pair of
individuals when we select one allele at random from374 The American Journal of Human Genetics 85, 364–376, Septemeach when IBD information is unknown, we have
CovðXij  mi,Xik  miÞ ¼ 2fðiÞjk s2i , for both noninbred and
inbred families and for both autosomal andX-linked genes.
Appendix C: An Algorithm for Simulating
Genotypes for a Given Pedigree
For a givenpedigreewithknownaffection status, genotypes
can be simulated with the following algorithm. Suppose
a family consists ofN genotyped individuals, amongwhich
the ﬁrst F individuals are founders. Let Xi andDi denote the
genotype score and affection status for the ith individual of
the family, and V denote the inheritance vector of the pedi-
gree. Suppose penetrances of the disease and the frequency
of the disease allele are speciﬁed prior to the simulation.
The probability of phenotype data conditional on
founders’ genotypes is
PrðD1/DN jX1/XFÞ
¼Pv PrðV ¼ vÞPrD1/DN jX1/XF , Xnf ¼ GðX1/XF ,vÞ,
in which genotypes of nonfounders Xnf are uniquely deter-
mined by founders’ genotypes and the inheritance vector.
The probability of each inheritance vector is the inverse of
2 to the 23 (N-F)th power. On the basis of this conditional
probability and the Hardy-Weinberg equilibrium assump-
tion, it is straightforward to obtain the probability of the
complete phenotype data, PrðD1/DNÞ.
We ﬁrst simulate genotypes of founders at the disease
locus according to a conditional probability distribution
given all levels of affection status:
PrðX1 ¼ x1/XF ¼ xF jD1/DNÞ
¼
QF
f¼1Pr

Xf ¼ xf

PrðD1/DN jX1 ¼ x1/XF ¼ xFÞP
gf
QF
f¼1Pr

Xf ¼ gf

PrðD1/DN jX1¼ g1/XF¼ gFÞ
:
We then simulate genotypes of nonfounders according
to the conditional probability distribution of inheritance
vectors, given the already simulated founder genotypes
as well as the complete phenotype data:
PrðV ¼ v jX1/XF, D1/DNÞ
¼ PrðV ¼ vÞPr

D1/DN jX1/XF , Xnf ¼ GðX1/XF,vÞ

PrðD1/DN jX1/XFÞ :
Thesimulationofmarkers follows immediatelyonthebasis
of simulated genotypes at the disease locus and speciﬁcation
of recombination fraction and linkagedisequilibriumparam-
eters. This algorithm has been implemented in a computer
program, the TDTPowerCalculator,5 for the empirical power
calculation of the TDT method in nuclear families.
Appendix D: A Robust Quantitative Trait
Association Test
We propose a robust score statistic for family-based quanti-
tative trait association analysis. Following the sameber 11, 2009
notation used in Chen and Abecasis,30 let yi and gi denote
vectors of the observed traits and genotypes at a marker,
respectively, for individuals in family i. The variance-
covariance matrix for family i is Ui. When a polygenic
model is ﬁtted to the phenotype data (without the use of
the genotype data), a vector of ﬁtted trait values is denoted
as E(yi)
(base), and the estimate of the variance-covariance
matrix is denoted as Ui
(base). We deﬁne the following score
statistic:
in which the matrix Cov(gi) consists of elements
Covðgij,gikÞ ¼ 2fðiÞjk s2W þ s2B. Estimation of the within-family
genotype variance s2W is described in Appendix B and
Equation 5, and the total genotype variance (the sum of
s2W and s
2
B) can be estimated as 2p(1-p), in which p is the
frequency estimate of the tested allele. This statistic is
approximately distributed as c2 with one degree of
freedom, and the score test can be shown to be robust to
nonnormality of the phenotypes (unpublished data).
Supplemental Data
Supplemental Data inclue one ﬁgure and one table and can be
found with this article online at http://www.ajhg.org/.
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